Literature DB >> 29394091

Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.

Andrea L Frump1, Mona Selej1, Jordan A Wood1, Marjorie Albrecht1, Bakhtiyor Yakubov1, Irina Petrache1,2, Tim Lahm1,2,3.   

Abstract

17β-Estradiol (E2) attenuates hypoxia-induced pulmonary hypertension (HPH) through estrogen receptor (ER)-dependent effects, including inhibition of hypoxia-induced endothelial cell proliferation; however, the mechanisms responsible for this remain unknown. We hypothesized that the protective effects of E2 in HPH are mediated through hypoxia-inducible factor 1α (HIF-1α)-dependent increases in ERβ expression. Sprague-Dawley rats and ERα or ERβ knockout mice were exposed to hypobaric hypoxia for 2-3 weeks. The effects of hypoxia were also studied in primary rat or human pulmonary artery endothelial cells (PAECs). Hypoxia increased expression of ERβ, but not ERα, in lungs from HPH rats as well as in rat and human PAECs. ERβ mRNA time dependently increased in PAECs exposed to hypoxia. Normoxic HIF-1α/HIF-2α stabilization increased PAEC ERβ, whereas HIF-1α knockdown decreased ERβ abundance in hypoxic PAECs. In turn, ERβ knockdown in hypoxic PAECs increased HIF-2α expression, suggesting a hypoxia-sensitive feedback mechanism. ERβ knockdown in hypoxic PAECs also decreased expression of the HIF inhibitor prolyl hydroxylase 2 (PHD2), whereas ERβ activation increased PHD2 and decreased both HIF-1α and HIF-2α, suggesting that ERβ regulates the PHD2/HIF-1α/HIF-2α axis during hypoxia. Whereas hypoxic wild-type or ERα knockout mice treated with E2 demonstrated less pulmonary vascular remodeling and decreased HIF-1α after hypoxia compared with untreated hypoxic mice, ERβ knockout mice exhibited increased HIF-2α and an attenuated response to E2 during hypoxia. Taken together, our results demonstrate a novel and potentially therapeutically targetable mechanism whereby hypoxia, via HIF-1α, increases ERβ expression and the E2-ERβ axis targets PHD2, HIF-1α, and HIF-2α to attenuate HPH development.

Entities:  

Keywords:  17β-estradiol; hypoxia-inducible factor 1α; hypoxia-inducible factor 2α; prolyl hydroxylase 2; pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 29394091      PMCID: PMC6039879          DOI: 10.1165/rcmb.2017-0167OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  54 in total

Review 1.  Estrogen receptor beta--a new dimension in estrogen mechanism of action.

Authors:  J A Gustafsson
Journal:  J Endocrinol       Date:  1999-12       Impact factor: 4.286

2.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.

Authors:  J F Couse; J Lindzey; K Grandien; J A Gustafsson; K S Korach
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

Review 3.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; Elvira Stacher; Jeffrey Robinson; Rahul Kumar; Brian B Graham
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

Authors:  Kirsty M Mair; Audrey F Wright; Nicholas Duggan; David J Rowlands; Martin J Hussey; Sonia Roberts; Josephine Fullerton; Margaret Nilsen; Lynn Loughlin; Matthew Thomas; Margaret R MacLean
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

6.  The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.

Authors:  Pinelopi P Kapitsinou; Ganeshkumar Rajendran; Lindsay Astleford; Mark Michael; Michael P Schonfeld; Timothy Fields; Sheila Shay; Jaketa L French; James West; Volker H Haase
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

7.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

8.  Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle.

Authors:  Tim Lahm; Ketan M Patel; Paul R Crisostomo; Troy A Markel; Meijing Wang; Christine Herring; Daniel R Meldrum
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-06-26       Impact factor: 4.310

9.  Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.

Authors:  Kevin White; Anne Katrine Johansen; Margaret Nilsen; Loredana Ciuclan; Emma Wallace; Leigh Paton; Annabel Campbell; Ian Morecroft; Lynn Loughlin; John D McClure; Matthew Thomas; Kirsty M Mair; Margaret R MacLean
Journal:  Circulation       Date:  2012-08-02       Impact factor: 29.690

10.  Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism.

Authors:  Tim Lahm; Paul R Crisostomo; Troy A Markel; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

View more
  13 in total

1.  Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome.

Authors:  Robert S Stearman; Quan M Bui; Gil Speyer; Adam Handen; Amber R Cornelius; Brian B Graham; Seungchan Kim; Elizabeth A Mickler; Rubin M Tuder; Stephen Y Chan; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

2.  Let's Talk about Sex: A Novel Mechanism by Which Estrogen Receptor β Limits Hypoxia-Inducible Factor Expression in Pulmonary Endothelial Cells.

Authors:  Larissa A Shimoda
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

Review 3.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

4.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

5.  Transcriptomic modifications in developmental cardiopulmonary adaptations to chronic hypoxia using a murine model of simulated high-altitude exposure.

Authors:  Sheila Krishnan; Robert S Stearman; Lily Zeng; Amanda Fisher; Elizabeth A Mickler; Brooke H Rodriguez; Edward R Simpson; Todd Cook; James E Slaven; Mircea Ivan; Mark W Geraci; Tim Lahm; Robert S Tepper
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-08       Impact factor: 5.464

Review 6.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

7.  Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases.

Authors:  An Huang; Sharath Kandhi; Dong Sun
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  The Role of Estrogen Receptors in Cardiovascular Disease.

Authors:  Laila Aryan; David Younessi; Michael Zargari; Somanshu Banerjee; Jacqueline Agopian; Shadie Rahman; Reza Borna; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

9.  Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1α in the Serum of Patients with Chronic Kidney Disease.

Authors:  Tianbiao Zhou; Wenshan Lin; Shujun Lin; Zhiqing Zhong; Yuanyuan Luo; Zhijun Lin; Weiji Xie; Weitao Shen; Kai Hong
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

Review 10.  Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.

Authors:  Ernestina M De Francesco; Marcello Maggiolini; Anna Maria Musti
Journal:  Int J Mol Sci       Date:  2018-07-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.